From: Tumor growth effects of rapamycin on human biliary tract cancer cells
Group | Apoptosisa | G0/G1 phase | G2 + M phase | S phase | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Mean | ±SE | P b | Mean | ±SE | P b | Mean | ±SE | P b | Mean | ±SE | P b |
control | 0.24 | 0.04 | Â | 32.56 | 1.01 | Â | 22.44 | 0.52 | Â | 25.44 | 0.85 | Â |
rapa 1 ng/mL | 0.28 | 0.02 | 0.33 | 35.98 | 1.21 | 0.55 | 21.24 | 0.35 | 0.085 | 17.96 | 0.23 | <0.001 |
rapa 5 ng/mL | 0.30 | 0.02 | 0.21 | 38.77 | 1.28 | <0.05 | 22.21 | 0.26 | 0.70 | 19.97 | 0.44 | <0.001 |
rapa 10 ng/mL | 0.52 | 0.04 | <0.05 | 37.09 | 0.50 | <0.05 | 24.45 | 0.70 | <0.05 | 15.88 | 0.29 | <0.001 |
rapa 20 ng/mL | 0.55 | 0.04 | <0.05 | 36.75 | 1.32 | <0.05 | 23.31 | 0.45 | 0.23 | 14.56 | 0.33 | <0.001 |
rapa 50 ng/mL | 0.42 | 0.05 | <0.05 | 33.16 | 0.44 | 0.60 | 26.05 | 0.14 | <0.05 | 16.15 | 0.37 | <0.001 |